Dechra Pharmaceuticals PLC banner
D

Dechra Pharmaceuticals PLC
F:1PK

Watchlist Manager
Dechra Pharmaceuticals PLC
F:1PK
Watchlist
Price: 45.2 EUR
Market Cap: €5.1B

Profitability Summary

Dechra Pharmaceuticals PLC's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Dechra Pharmaceuticals PLC

Margins Comparison
Dechra Pharmaceuticals PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
Loading...
Loading...
US
Zoetis Inc
NYSE:ZTS
51.7B USD
Loading...
Loading...
Loading...
DE
Bayer AG
XETRA:BAYN
39.4B EUR
Loading...
Loading...
Loading...
US
Elanco Animal Health Inc
NYSE:ELAN
12.5B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
879B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
573.4B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
257.8B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
224B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
231.4B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.7B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
240.1B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Dechra Pharmaceuticals PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Zoetis Inc
NYSE:ZTS
51.7B USD
Loading...
Loading...
Loading...
Loading...
DE
Bayer AG
XETRA:BAYN
39.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Elanco Animal Health Inc
NYSE:ELAN
12.5B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
879B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
573.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
257.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
224B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
231.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.7B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
240.1B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Dechra Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett